Spectral AI Appoints Darcy Bajko as Chief Commercial Officer to Lead DeepView® System Launch

Spectral AI has appointed Darcy Bajko as its new Chief Commercial Officer, effective July 31, 2026. This key leadership appointment is intended to drive the global commercial launch of the company's recently FDA-cleared DeepView® System for burn indication, marking a strategic shift from product development to commercial execution.

Key Details

• Appointment: Darcy Bajko will assume the role of Chief Commercial Officer, bringing commercialization experience from MediView XR, Smith+Nephew, and Integra LifeSciences.
• Compensation Package: The employment agreement includes a $315,000 annual base salary, an annual target bonus of up to 30% of base pay, and a stock option grant to acquire 150,000 shares vesting over three years.
• Strategic Goal: Ms. Bajko is tasked with building out the commercial organization and leading the sales launch of the DeepView® System, with the company aiming to secure its first commercial sales by the end of 2026.